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Abstract
Anemia has an important role in exercise performance. However, the direct link between
rapid changes of hemoglobin and exercise performance is still unknown.To find out more
on this topic, we studied 18 beta-thalassemia major patients free of relevant cardiac dys-
function (age 33.5±7.2 years,males = 10). Patients performed a maximal cardiopulmolmon-
ary exercise test (cycloergometer, personalized ramp protocol, breath-by-breath
measurements of expired gases) before and the day after blood transfusion (500 cc of red
cell concentrates). After blood transfusion, hemoglobin increased from 10.5±0.8 g/dL to
12.1±1.2 (p<0.001), peak VO2 from 1408 to 1546mL/min (p<0.05), and VO2 at anaerobic
threshold from 965 to 1024mL/min (p<0.05). No major changes were observed as regards
heart and respiratory rates either at peak exercise or at anaerobic threshold. Similarly, no
relevant changes were observed in ventilation efficiency, as evaluated by the ventilation vs.
carbon dioxide production relationship, or in O2 delivery to the periphery as analyzed by the
VO2 vs. workload relationship. The relationship between hemoglobin and VO2 changes
showed, for each g/dL of hemoglobin increase, a VO2 increase = 82.5 mL/min and 35 mL/
min, at peak exercise and at anaerobic threshold, respectively. In beta-thalassemia major
patients, an acute albeit partial anemia correction by blood transfusion determinates a rele-
vant increase of exercise performance, observed both at peak exercise and at anaerobic
threshold.
Introduction
Circulating hemoglobin (Hb) and exercise performance are strictly linked. Indeed, a high Hb
level is considered a must for elite athletes just as anemia correction is a must in several chronic
diseases such as heart failure, thalassemia, renal insufficiency, hematopoietic disorders, just to
mention the most frequent ones where anemia has a pivotal role in patients’ well-being and
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often in their prognosis [1–3]. In the clinical field, the gold standard for exercise evaluation is
peak exercise oxygen uptake (peak VO2), that is peak exercise cardiac output x artero-venous
O2 content difference. The latter is Hb x O2sat in the systemic artery—Hb x O2sat in the central
vein. However, no clear-cut data are presently available to define the quantitative role of Hb
change in exercise performance in chronic diseases. Indeed, anemia correction, for instance in
chronic kidney disease and heart failure, is usually progressive and obtained by iron and/or
erythropoietin supplementation [4–7]. Accordingly, over time, anemia correction improves ex-
ercise performance by at least two mechanisms: a direct action on blood Hb level, and an indi-
rect action related to a training effect by physical activity which progressively increases over
time as anemia severity decreases. However, measurements showing the isolated effect of ane-
mia correction in chronic diseases are presently lacking. We have previously indirectly and
semi-quantitatively assessed this issue by analyzing the correlation between circulating Hb and
peak VO2in a large population of heart failure patients [2]. In this specific population, we
showed that, for each gram of Hb increase, VO2 increase was 109 mL/min at peak and 74 mL/
min at the anaerobic threshold (AT). Thalassemia patients have a reduced exercise capacity
which is due, as well as to anemia, to several causes including physical deconditioning, low rate
of high energy phosphate production and utilization, and reduced oxidative capacity of myo-
cytes [8, 9]. Moreover, a cardiogenic cause of exercise limitation is also frequently observed,
being cardiac involvement frequently observed in thalassemia [10–13]. Indeed, on top of iron
overload, also myocarditis, pulmonary hypertension and diabetes frequently affect cardiac
function in beta-thalassemia major (TM) patients [14–16]. TM patients are a unique popula-
tion. Indeed, they regularly undergo blood transfusion, so that the direct influence of Hb in-
crease on exercise performance can easily be assessed. This study was performed to assess the
role of Hb increase by hemotransfusion on VO2 both at peak exercise and at AT in TM
patients.
Methods
We studied 18 consecutive TM patients in stable clinical condition. Anthropometric data are
reported in Table 1. Eight patients had previously undergone splenectomy and were treated
with low-dose aspirin. Seven patients received a supplement of thyroid hormone. Patients were
regularly followed at the Hematology Centre of Hospital E. Morelli, Reggio Calabria, Italy.
Only one patient was an active smoker and showed increased myocardial iron at nuclear mag-
netic resonance. Renal function was normal in all but two subjects, who showed minor renal
insufficiency (eGFR 90–60 mL/min). Moderate left ventricular hypertrophy was observed in
one case. Three patients were diabetic and one was hypertensive on beta-blocker treatment. Pa-
tients were instructed to avoid any special activity and to maintain their usual diet and drinking
Table 1. Population characteristics.
n Mean
AGE (years) 33.50 ± 7.16
GENDER (n) MEN 10
WOMEN 8
WEIGHT (kg) 62.3 ± 12.2
BMI (kg/m2) 23.39 ± 4.18
BMI = Body mass index.
doi:10.1371/journal.pone.0127553.t001
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habits. Patient assessment included clinical evaluation, laboratory tests, echocardiography and
cardiopulmonary exercise test.
This report is based on the results of cardiopulmonary exercise tests performed immediately
before and the day after blood transfusion. Cardiopulmonary exercise test (CPET) was carried
out on a cycloergometer (Sensor Medics, V-max 400, Yorba Linda, CA) with a personalized
ramp protocol aimed at obtaining peak exercise in 8 to 12 minutes [9]. Exercise protocol was
the same for each patient before and after blood transfusion. All subjects had done at least one
CPET before the study; we considered the previous ones as familiarization tests, and we used
them to better select ramp protocols in each individual. Patients were instructed to pedal at the
speed of 60 revolutions per minute. Effort was self-terminated by the subjects when they
claimed that they had reached maximal effort, regardless of the respiratory quotient reached.
During the exercise test, twelve-lead ECG, blood pressure, and arterial oxygen saturation were
monitored. VO2, ventilation (VE) and carbon dioxide production (VCO2) were measured
breath by breath. VO2, VE and VCO2 data are reported as 20-second average. AT was mea-
sured by V-slope analysis of VO2 and VCO2, and it was confirmed analyzing the ventilatory
equivalents and the end-tidal pressures of CO2 and O2. Linear regression was applied to the
VO2/work relationship measured throughout the exercise, while the VE/VCO2 relationship
was calculated from one minute after the beginning of loaded pedaling to the end of the isocap-
nic buffering period [17]. Predicted peak VO2 values were calculated according to Hansen-
Wasserman equations [18]. Cardiopulmonary exercise tests were performed in the morning
immediately before and the day after blood transfusion (two units of red blood cells = 500 mL).
Statistical analysis
Data are reported as mean ± standard deviation. Differences between pre and post hemotrans-
fusion data were analyzed by paired t-test.
The study was part of the routine activity, and data analysis has been approved by the Insti-
tutional Review Board of Ospedale Morelli (Reggio Calabria, Italy). All patients signed a writ-
ten informed consent.
Results
Echocardiographic data showed the absence of relevant cardiac involvement, being ejection
fraction 60.7±3.6% (range 56–68), left ventricle end systolic volume 32.7±11.1 (mL), left ventri-
cle end diastolic volume 77.3±19.1 (mL); E/A was>1 in all but two subjects, E/E’ was 5.7±0.9
(range 5–7), and tricuspid annular plane systolic excursion was 20.9±2.7 cm (range 18–26). No
relevant correlation was found between exercise performance and echo-Doppler parameters.
After red blood cell transfusion, hemoglobin increased from 10.5±0.8 g/dL to 12.1±1.2 (p =
<0.001). Resting heart rate was 88±10 b/min and 82±8 b/min (p = 0.027) before and the day
after blood transfusion, respectively. Specifically, no subject had symptoms or ECG changes
suggestive of exercise-induced myocardial ischemia. All patients performed uneventful maxi-
mal cardiopulmonary exercise tests (peak RER = 1.06±0.09 and 1.10± 0.07 p = 0.29), respec-
tively. On the average, exercise performance was low, being it 52.1±13.0% of predicted values
before blood transfusion. After transfusion, exercise performance remained low, although it in-
creased to 57.7±14.01% (p = 0.015, 10.7% increase). Major cardiopulmonary exercise data are
reported in Table 2. After blood transfusion, VO2 increased both at AT and at peak exercise in
parallel with a workload increase. On the average, for 1 g of Hb, VO2 increased by 82.5mL/min
and 5mL/min at peak and at AT, respectively (Fig 1).
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Discussion
This study shows that acute partial anemia correction by blood transfusion in TM patients is
associated to a relevant increase of exercise performance, as evaluated both at peak exercise
and at AT.
The population we studied is composed by young adults with TM. Their exercise perfor-
mance is severely impaired as in similar populations previously studied [8, 9, 19]. Several are
the causes of exercise limitation in TM patients on top of anemia itself, including cardiac func-
tion, sedentary attitude and muscle deconditioning, and likely a not yet completely defined
form of myopathy [8]. No major cardiac involvement was evident in this population, likely due
to appropriate TM treatment and regular follow-up of patients [20]. Indeed, echocardiographic
reports showed normal left ventricular systolic function and volumes and, in the majority of
cases, normal diastolic function. A relevant deconditioning is also likely. Indeed, because they
are considered as diseased subjects, TM patients are told since childhood to avoid exercise, by
family members and even by medical personnel, although there is no indication in favor of this
suggestion. Indeed, none of our patients had been involved in a physical rehabilitation pro-
gram, nor performed regular physical activity. As a matter of fact, we previously showed that
the few thalassemia patients who perform regular physical activity do not show muscular de-
conditioning, which was present in patients with a more sedentary lifestyle [9].
Consequence of the deconditioning and of the scarce habit to exercise of some subjects is
the RER value we recorded at peak exercise. CPET was always interrupted by the patients when
they claimed that they had performed a maximal effort, and never by the medical personnel.
Consequently, the average RER value, both in the first and the second test, suggests that the
Table 2. Cardiopulmonary exercise test measurements before and after blood transfusion.
PRE POST p
VO2peak (mL/min) 1408 ±333 1546 ± 471 0.026
VO2peak AT (mL/min) 965 ± 26 1024 ± 26 0.044
VO2peak/kg (mL/min/kg) 23.1 ± 6.4 25.5 ± 7.9 0.009
VO2peak/kg AT (mL/min/kg) 15.8 ± 4.6 17.1±5.1 0.011
VCO2peak (mL/min) 1.5 ± 0.4 1.7 ±0.5 0.021
VCO2peak AT (mL/min) 0.9 ± 0.3 1.0 ±0.3 0.047
O2 Pulse peak (mL/beat) 8.9 ± 2.0 10.1 ± 2.5 0.0014
O2 Pulse peak AT (mL/beat) 7.8 ± 2.2 8.6 ± 1.7 0.0018
Workload (watt) 91 ± 26 101 ± 34 0.013
Workload AT (watt) 55 ± 23 61 ± 24 0.006
TV peak (L) 1.5 ±0.4 1.4 ± 0.4 0.5
TV AT (L) 1.1 ± 0.4 1.1 ± 0.4 0.75
VE peak (L/min) 40.5 ± 9.5 44.5 ± 11.7 0.013
VE AT (L/min) 24.5 ± 6.0 26.3 ± 6.8 0.067
HR peak (bpm) 159 ± 15 156 ± 20 0.158
HR AT (bpm) 126 ± 13 123 ± 15 0.163
RR peak (bpm) 30.6 ± 8.6 32.7 ± 9.7 0.021
RR AT (bpm) 23.7 ± 8.0 24.6 ±7.9 0.208
VO2/work (mL/min/watt) 10.4 ± 1.2 10.7 ± 1.2 0.286
VE/VCO2slope 23.7 ± 3.8 22.8 ± 4.2 0.287
VO2 = Oxygen uptake, AT = anaerobic threshold, VCO2 = Carbon dioxide production, TV = tidal Volume, VE = Ventilation, HR = heart rate,
RR = respiratory rate.
doi:10.1371/journal.pone.0127553.t002
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Fig 1. Effect of transfusion on VO2 and hemoglobin. VO2 and hemoglobin blood levels before and after blood transfusion at peak exercise (panel A) and
at the anaerobic threshold (panel B). * = p <0.05 ** = p<0.001. Hb = hemoglobin, VO2 peak = oxygen uptake at peak exercise, VO2AT = oxygen uptake at
anaerobic threshold.
doi:10.1371/journal.pone.0127553.g001
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effort was maximal or nearly maximal from a metabolic point of view [21]. However, the huge
standard deviation also suggests that this was not the case in some subjects—and likely in those
subjects with a less active lifestyle.
Peak exercise improved in TM patients after blood transfusion. However, peak exercise data
are dependent on patients’ effort, and one may speculate that, after blood transfusion—which
is impossible to blind—patients are more confident with the effort, and that they consequently
exercise more strenuously. Indeed, albeit not statistically significant, RER was higher in the
post-transfusion test than in the pre-transfusion test. Notably, exercise improvement after
blood transfusion was observed both at peak exercise and at AT, the latter being effort indepen-
dent. Moreover, AT represents a more everyday life effort, suggesting that blood transfusion in
TM patients does not only improve peak exercise performance, but also daily activity.
We have previously shown that, in a chronic heart failure population with reduced exercise
capacity, the correlation between VO2 and Hb suggests a VO2 increase of 109mL/min and 74
mL/min for each gram of Hb at peak exercise and at AT, respectively. These values were ob-
tained considering a huge population, but other variables related to peak VO2, such as cardiac
output and O2 extraction, were not considered [22]. Few other studies in heart failure provided
different peak VO2 changes for each gram of Hb increase [4–7]. However, in these studies, Hb
increase was obtained by iron and/or erythropoietin treatment, which implies a prolonged
treatment period during which a slow, progressive Hb increase is achieved. Consequently, as
Hb increases, patients’ well-being increases, with the likely possibility of a training effect. In the
present study, we observed a lower increase of VO2 for each gram of Hb in TM patients, specif-
ically 82.5 and 35 mL/min/g at peak and at AT, respectively. Our study, albeit apparently sim-
plistic and, at a first glance, even trivial, is unique, because Hb increase was acute so that
cardiac output and O2 extraction changes are unlikely just as a training effect is. The observa-
tion at AT is particularly relevant. Indeed, up to AT, body metabolism is mainly aerobic and
blood flow independent, while above AT an anaerobic component is added to the aerobic one
and a non–blood-flow-dependent component of ATP production develops [17, 23]. Therefore,
the fact that AT is postponed and has a significantly higher VO2 is an uncontaminated index of
anemia correction on exercise performance. However, 35 mL/min/g is the amount of VO2 in-
crease calculated at AT per gram of Hb increase; this is likely the true VO2 increase for each
gram of Hb change. Indeed, the extent of VO2 increase at peak exercise, 82.5 mL/min/g, is am-
plified by the effects of anemia correction on exercise myocardial function and therefore on
cardiac output.
Few study limitations should be acknowledged. Firstly, whenever an intervention is evaluat-
ed, a correct analysis implies that some patients are studied without the intervention (sham pa-
tients) and some other with the active intervention, or that the time course of the observation
is variable. For logistic reasons, we limited our evaluation to a before and after intervention
analysis. Secondly, the effects of blood transfusion on exercise performance should be consid-
ered only within the Hb values we observed and cannot be extrapolated to higher or lower Hb
blood values. Thirdly, blood transfusion implies an increase of red blood cells but also an in-
crease in intravascular volume. The latter may influence exercise hemodynamics and therefore
change peak VO2 independently of Hb changes. No data are available in this regard in TM pa-
tients. However, rapid saline infusion is associated with a reduction of peak VO2 in healthy in-
dividuals [24, 25] and in chronic heart failure patients [26], suggesting that the effects on
exercise performance are mainly related to Hb changes and not to intravascular volume
changes. Fourthly, Hb increases during exercise in all subjects, including TM patients. Howev-
er, the exercise-induced hemoconcentration is blunted in thalassemia patients, and it is negligi-
ble in thalassemia patients who have undergone splenectomy [9]. Indeed, we previously
reported, in thalassemia intermedia patients, an exercise-induced Hb increase of 0.4±0.2 g/dL
Blood Transfusion Improves Exercise Performance in Thalassemia
PLOS ONE | DOI:10.1371/journal.pone.0127553 May 26, 2015 6 / 8
and 1.0±0.4 g/dL in patients who had and who had not undergone splenectomy, respectively
[9]. Notably, 8 out of our 18 patients had previously undergone splenectomy for clinical rea-
sons. Moreover, exercise-induced hemoconcentration only takes place with a relevant effort, as
it is mainly due to intracellular lactic acid increase [22, 27]. Accordingly, data at AT are unaf-
fected by exercise-induced hemoconcentration. Furthermore, we did not perform a peak exer-
cise blood sample as we wanted to reduce patients’ discomfort as much as possible and to avoid
any interference of blood sampling with maximal exercise performance which is a likely event
in such fragile subjects. However, the lack of peak exercise Hb measurement cannot influence
the pre and post blood transfusion peak VO2 vs Hb relationship. Finally, the number of TM pa-
tients we studied is definitely small. More cases are certainly needed, possibly with a higher Hb
range, to confirm our findings.
In conclusion, we showed that blood transfusion increases exercise performance in TM pa-
tients with a VO2 increase for each Hb g = 82.5 mL/min and 35 mL/min, at peak exercise and
at AT, respectively.
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